Home
Clinical Resources Search
PQI: Acalabrutinib (Calquence®) In Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Acalabrutinib (Calquence®) In Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Download PQI pdf 0.16MB

Last Updated: March 12, 2023

By: Trey McNiel, PharmD

About this PQI

The purpose of this PQI is to discuss the clinical considerations around the use of acalabrutinib (Calquence®) to optimize the outcomes for patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

More About This PQI

PQI in Action Articles:

Acalabrutinib_calquence_SLL pdf 2.31MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Chronic Lymphocityic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Mantle Cell Lymphoma Acalabrutinib Calquence

PQI

Frequently Searched

Supported by

Acalabrutinib (Calquence®) In Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

PQI in Action: Fruquintinib (Fruzaqla®)

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

S9 E3: Firefighter Health & Cancer Prevention

S9 E2: Love Languages in Cancer Care

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

S8 Bonus Eps 2: Inside ASCO 2025

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Venetoclax (Venclexta®) Use in Chronic Lymphocytic Leukemia

PQI: Patient Screening for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management

PQI in Action: Zanubrutinib (Brukinsa®) Patient Selection and Management – 2

PQI in Action: Zanubrutinib (Brukinsa®) Patient Selection and Management

Video: BRUKINSA® (Zanubrutinib) for Treatment of Mantle Cell Lymphoma

PQI in Action: Acalabrutinib (Calquence®) in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI in Action: Acalabrutinib (Calquence®) in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

S9 E3: Firefighter Health & Cancer Prevention

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

S9 E2: Love Languages in Cancer Care